Study guide

2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories

Key Takeaways Explain This Topic AI

Systematic 12-lead ECG interpretation maps ST-segment elevation, depression, and reciprocal changes to specific coronary artery vascular distributions (LAD, RCA, LCx, and PDA).

High-risk ECG equivalents such as Wellens Syndrome (biphasic or deeply inverted T waves in V2-V3) and De Winter Pattern (upsloping ST depression with tall symmetrical T waves) signal critical proximal LAD occlusion requiring urgent catheterization despite lacking classic ST elevation.

Posterior wall STEMI presents as reciprocal horizontal ST-segment depression and tall R waves in V1-V3; confirmation requires placing posterior leads V7-V9 to identify ST elevation ≥ 0.5 mm.

High-sensitivity cardiac troponin (hs-cTn) protocols leverage rapid 0/1-hour or 0/2-hour baseline and absolute delta measurements, enabling significantly accelerated rule-out and rule-in of myocardial infarction compared to standard troponin or CK-MB assays.

Last updated: August 2026

Electrophysiological Stages of Ischemia, Injury, and Infarction

The 12-lead electrocardiogram (ECG) is the single most critical immediate diagnostic tool in Acute Coronary Syndromes. Ischemia, injury, and infarction represent a temporal and electrophysiological continuum reflected in distinct wave-form alterations.

1. Ischemia (T-Wave Alterations)

Myocardial ischemia alters cellular action potential duration and repolarization dynamics. The earliest electrophysiological manifestation of hyperacute ischemia is the appearance of hyperacute T waves —tall, broad-based, symmetrical, peaked T waves in leads overlying the ischemic zone, occurring within minutes of acute coronary occlusion. As ischemia persists, repolarization is delayed in the subendocardium, resulting in symmetrical T-wave inversion (measuring ≥ 1.0 mm deep in two contiguous leads).

2. Injury (ST-Segment Shift)

Cellular injury alters the resting membrane potential of injured myocytes relative to healthy tissue, generating a voltage gradient during the phase of electrical diastole (TP segment) and systole (ST segment), known as the current of injury :

ST-Segment Elevation (Transmural Injury): Overlying epicardial leads record a positive displacement of the J-point (junction of the QRS complex and ST segment). Diagnostic STEMI criteria require ≥ 1.0 mm ST elevation in all limb leads, or ≥ 1.5 mm in females, ≥ 2.0 mm in males ≥ 40 years, and ≥ 2.5 mm in males <40 years in precordial leads V2-V3.

ST-Segment Depression (Subendocardial Injury): Overlying leads record horizontal or downsloping J-point depression ≥ 0.5 mm in two contiguous leads.

Reciprocal Changes: Ischemic ST elevation in leads facing the injured epicardial surface is mirrored by reciprocal ST-segment depression in anatomically opposite leads (e.g., inferior ST elevation with high lateral I and aVL reciprocal ST depression).

3. Infarction (Pathological Q Waves & Loss of R Wave Height)

Irreversible myocardial cell death creates an electrically silent window in the ventricular wall. Depolarization vectors flow away from the necrotic tissue toward surviving myocardium, producing pathological Q waves (defined as a Q wave duration ≥ 0.03 seconds and depth > 1 mm or a Q wave depth ≥ 25% of the total R-wave amplitude in that lead) and progressive loss of precordial R-wave height.

Loading diagram... 12-Lead ECG Anatomic Mapping and Lead Grouping

Comprehensive Lead Localization & Coronary Artery Mapping

Accurate lead localization allows bedside nurses to predict the culprit coronary artery, anticipate specific hemodynamics, and monitor for expected conduction block patterns.

12-Lead ECG Coronary Territory Localization Table

ECG Leads Anatomic Territory Culprit Coronary Artery Secondary / Branch Vessels Reciprocal Leads Clinical & Hemodynamic Pearls

V1, V2 Septal Left Anterior Descending (LAD) First Septal Perforator (S₁) II, III, aVF (minor) Risk of bundle branch blocks (RBBB), Mobitz II or 3rd-degree heart block; ventricular septal rupture

V3, V4 Anterior Wall Left Anterior Descending (LAD) Diagonal Branches (D₁, D₂) II, III, aVF High risk of left ventricular heart failure, cardiogenic shock, and ventricular free wall rupture

I, aVL, V5, V6 Lateral Wall Left Circumflex (LCx) or LAD Obtuse Marginal (OM₁, OM₂) or Diagonal (D₁) II, III, aVF Often accompanies anterior or inferior MIs; monitor for papillary muscle rupture causing acute mitral regurgitation

II, III, aVF Inferior Wall Right Coronary Artery (RCA) [85%] or LCx [15%] Posterior Descending Artery (PDA) I, aVL High vagal tone (bradycardia), Mobitz I (Wenckebach) block; mandatory 15-lead ECG to check V4R for RV involvement

V3R, V4R Right Ventricular Right Coronary Artery (RCA) Right Ventricular Branches V5, V6 Preload dependent! Avoid nitrates and diuretics; administer IV fluid boluses to maintain RV fill

V7, V8, V9 True Posterior Right Coronary Artery (RCA) or LCx Posterolateral / PDA ST depression & tall R in V1-V3 Look for ST depression, tall broad R wave (R/S >1), and upright T wave in V1-V3; confirm with V7-V9 ST elevation ≥ 0.5 mm

High-Risk Equivalent ECG Patterns

Several ECG presentations signal impending anterior wall disaster or obscured infarction, requiring immediate catheterization lab activation despite lacking classic ST-segment elevation.

1. Wellens Syndrome (Critical Proximal LAD Stenosis)

Wellens syndrome represents pre-infarction stenosis of the high proximal LAD. It is characterized by characteristic T-wave changes in leads V2 and V3 observed during pain-free intervals after chest pain has resolved. Wellens features two distinct variants:

Type A (~25% of cases): Biphasic T waves in V2 and V3 (initial positivity followed by deep negative terminal inversion).

Type B (~75% of cases): Deeply and symmetrically inverted T waves in V2 and V3 (and often V4-V5).

Critical Clinical Nursing Alert: Cardiac biomarkers are typically normal or minimally elevated, and ST segments show no elevation. However, stress testing in a patient with Wellens pattern is strictly contraindicated because it can precipitate massive transmural anterior STEMI, fatal arrhythmias, or sudden cardiac death. Immediate invasive coronary angiography is mandatory.

2. De Winter ECG Pattern (Hyperacute Proximal LAD Occlusion)

De Winter pattern is a STEMI-equivalent present in roughly 2% of acute LAD occlusions. The ECG demonstrates:

1 to 3 mm upsloping ST-segment depression at the J-point in precordial leads V1 through V6.

Prominent, tall, broad-based, symmetrical hyperacute T waves continuing directly from the depressed ST segment.

0.5 to 1.0 mm ST-segment elevation in lead aVR .

This pattern reflects total proximal LAD occlusion without collateral flow. Nurses must recognize De Winter as a STEMI equivalent demanding immediate emergent cardiac catheterization.

3. True Posterior Wall Myocardial Infarction

Because standard 12-lead ECGs do not place electrodes over the posterior chest, a true posterior MI appears as "mirror image" ST-segment changes in anterior leads V1, V2, and V3:

Horizontal ST-segment depression in V1-V3.

Tall, broad R waves (R/S ratio >1.0 in V1-V2).

Upright, prominent T waves in V1-V3.

Confirmation requires obtaining a 15-lead ECG with posterior leads V7 (left posterior axillary line), V8 (left mid-scapular line), and V9 (left paraspinal area). ST-segment elevation ≥ 0.5 mm in leads V7-V9 confirms acute posterior STEMI.

4. Right Ventricular (RV) Myocardial Infarction

Right ventricular infarction complicates up to 50% of inferior STEMIs (RCA occlusion). Standard ECG shows ST elevation in II, III, aVF (with ST elevation in lead III > lead II). Right-sided precordial leads must be obtained immediately; ST-segment elevation ≥ 1.0 mm in lead V4R is highly sensitive and specific for RV necrosis.

Cardiac Biomarker Kinetics & High-Sensitivity Troponin Protocols

Serum cardiac biomarkers provide quantitative evidence of myocardial necrosis. Understanding biomarker kinetics enables accurate diagnosis, timing of ischemic injury, and detection of early re-infarction.

1. High-Sensitivity Cardiac Troponin (hs-cTnI & hs-cTnT)

Cardiac Troponins I and T are regulatory proteins of the myofibrillar thin filament controlling calcium-mediated actin-myosin interaction. Small intracellular cytosolic pools are released rapidly upon membrane disruption, followed by sustained release from degrading structural filaments.

Conventional Troponin Kinetics: Initial elevation detectable at 3-4 hours post-injury, peak concentration at 18-24 hours, remaining elevated for 7-10 days (cTnI) or up to 14 days (cTnT).

High-Sensitivity Troponin (hs-cTn): Modern hs-cTn assays detect troponin concentrations at the nanogram per liter (ng/L) level with a coefficient of variation ≤ 10% at the 99th percentile URL. hs-cTn rises within 1 to 2 hours post-onset of ischemia.

ESC / ACC 0/1-Hour and 0/2-Hour Rapid Protocols: Clinical algorithms utilize baseline hs-cTn values combined with absolute changes (delta, Δ) at 1 or 2 hours. A very low baseline hs-cTn rules out MI immediately, whereas a significant 1-hour or 2-hour delta rise confirms acute myocardial injury, bypassing older 6-hour observation periods.

2. Creatine Kinase-MB (CK-MB)

CK-MB is an isoenzyme of creatine kinase predominantly located in myocardium (though small amounts exist in skeletal muscle). Initial rise occurs at 4-6 hours, peaking at 18-24 hours, and returning to baseline within 48 to 72 hours .

Primary Clinical Utility: CK-MB normalizes within about 3 days, which historically made it the marker of choice for early re-infarction . The Fourth Universal Definition of Myocardial Infarction has superseded that practice: when re-infarction is suspected, measure cardiac troponin immediately and repeat it 3–6 hours later, and a >20% rise in the second sample establishes re-infarction. CK-MB is now a legacy fallback where serial high-sensitivity troponin is unavailable.

3. Myoglobin

Myoglobin is a small cytoplasmic oxygen-binding protein found in cardiac and skeletal muscle. It rises rapidly within 1 to 3 hours , peaks at 6-8 hours, and clears completely within 24 hours. While highly sensitive early on, myoglobin lacks cardiac specificity (elevations occur with trauma, rhabdomyolysis, or renal failure).